Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Cardiovascular system > Haemostasis 2 > Flashcards

Haemostasis 2 Flashcards

1
Q

What is meant by abnormal bleeding

A 
Bleeding that is:
‘Spontaneous’
Out of proportion to the trauma/injury
Unduly prolonged 
Restarts after appearing to stop
Recurrent nose bleeds and bruising in absence of injury are examples
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give examples of an abnormal bleeding history

A

Epistaxis not stopped by 10 mins compression or requiring medical attention/transfusion.
Cutaneous haemorrhage or bruising without apparent trauma (esp. multiple/large).
Prolonged (>15 mins) bleeding from trivial wounds, or in oral cavity or recurring spontaneously in 7 days after wound. Spontaneous GI bleeding leading to anaemia.
Menorrhagia requiring treatment or leading to anaemia, not due to structural lesions of the uterus.
Heavy, prolonged or recurrent bleeding after surgery or dental extractions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What proportion of the population have easy bruising

A

12%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Summarise the normal haemostatic response

A

Vessel constriction
Vascular smooth muscle cells contract locally
Limits blood flow to injured vessel


Formation of an unstable platelet plug
platelet adhesion
platelet aggregation
Limits blood loss + provides surface for coagulation (primary haemostasis)

Stabilisation of the plug with fibrin
blood coagulation
Stops blood loss

Vessel repair and dissolution of clot
Cell migration/proliferation & fibrinolysis
Restores vessel integrity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the defects of primary haemostasis

A

Defect:
* Collagen – Vessel Wall:
o E.G. Steroid Therapy (makes walls weak), age and scurvy.
* Von Williebrand Factor (VWF):
o Von Williebrand Disease – a genetic deficiency of VWF.
* Platelets:
o Aspirin and other drugs affect platelet activity.
o Thrombocytopenia is a disease that affects the number of platelets in the bloodstream (presents with petechiae).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a consequence of no VWF

A 
Platelets cannot stick
Can't bind to collagen (secondary binding)
No plug for coagulation
Platelets need VWF to slow them down
leads to continuous bleeding.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is petechiae

A

Small breaks in blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Compare the normal and abnormal (no VWF) haemostatic response

A
  • The normal primary haemostatic response:
    o Endothelial wall damage à exposed collagen binds to VWF à VWF binding sites exposed and platelets aggregate onto VWF à primary haemostatic plug formation.
  • VMF Deficiency (VWD) response:
    o Endothelial wall damage à platelets can only bind to exposed collagen (in some situations) as no VWF à less aggregation and NO primary platelet plug formation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the bleeding patterns that may arise due to defects in primary haemostasis

A 
Immediate
 Easy bruising
 Nosebleeds (prolonged: >20 mins)
 Gum bleeding (prolonged)
 Menorrhagia (anaemia)
 Bleeding after trauma/surgery 
 Petechiae (specific for thrombocytopenia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the defects in secondary haemostasis

A

Generation of thrombin. Defect in the fibrin mesh formation:
* Thrombin converts fibrinogen to fibrin which forms the insoluble mesh around the platelets to stabilise them.
problem with blood coagulation, preventing stabilisation of plug with fibrin - deficiency of/defective coagulation factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe thrombin generation and haemophilia

A

This thrombogram visualises the process of coagulation.

  • The lag time after the TF (tissue factor) trigger due to the time taken to generate the cofactors and anticoagulant enzymes before the burst of thrombin.
  • In haemophilia, F8 is missing which causes a failure in thrombin burst à slower and lower increase in thrombin à clot does not stabilise.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Where is stabilisation by coagulation particularly important

A

Larger blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give some examples of secondary haemostasis

A

Genetic
Haemophilia: FVIII or FIX deficiency

Acquired
Liver disease (most coagulation factors are made in the liver)

Drugs (warfarin – inhibits synthesis, other block function)

Dilution (results from volume replacement)

Consumption (Disseminated Intravascular Coagulation*) (acquired)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe haemophilia

A

prevents thrombin burst because no FVIII, so inadequate fibrin mesh forms to stabilise the platelet plug - plug not stabilised so will fall apart, stopping then starting bleeding again

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the features of DIC

A

Generalised activation of coagulation – Tissue factor inside vasculature
Associated with sepsis, major tissue damage, inflammation
Consumes and depletes coagulation factors & platelets
Activation of fibrinolysis depletes fibrinogen
Major inflammatory reaction in sepsis causes inflammatory mediator e.g. IL6 production
IL-6/mediators stimulate cells (monocytes/endothelial cells) to make tissue factor and express on surface (inside blood vessels - so coagulation occurs inside intact blood vessels)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the consequences of DIC

A

Widespread bleeding, from iv lines, bruising, internal

Deposition of fibrin in vessels causes organ failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the bleeding patterns in secondary haemostasis

A

do form a platelet plug but not stabilised so:
Delayed and prolonged
Deeper inside joints and muscles
Not from small cuts (primary haemostasis ok)
Nosebleeds are rare
Bleeding after trauma/surgery
Bleeding after IM injections

Fibrin falls apart- attempts to reform- falls apart again.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is ecchymosis

A

Easy bruising

Hallmark of all bleeding disorders.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is hemarthrosis

A

Spontaneous bleeding in the joints and muscles- hallmark of haemophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can we prevent dilutions

A

Replace with plasma (coagulation factors) instead of replacing RBC only.

21
Q

When will bleeding occur

A 
Reduced coagulation factors and platelets
Increased Fibrinolytic 
factors,
Anticoagulant 
proteins
22
Q

Describe the haemostatic response in patients with haemophilia

A
  • The normal fibrin clot formation mechanism:
    o Thrombin is formed from generates fibrin from fibrinogen à fibrin crosslinks via F13a (mediated by thrombin) à stable clot forms.
  • Haemophilia response mechanism:
    o Deficiency in F8 or F9 causes a lack of thrombin to be produced à less fibrinogen to fibrin so less fibrin à less crosslinking as less F13a produced via thrombin.
23
Q

Outline problems with fibrinolysis

A

rarer, but excess fibrinolytic activity will remove fibrin mesh too rapidly

24
Q

Describe the causes of the problems associated with fibrinolysis

A

Excess fibrinolytic: drug administration (e.g. Strokes) or some tumours
Deficient antifibrinolytic: antiplasmin deficiency (genetic)

25
Q

Describe unbalanced haemostasis

A

anticoagulant excess
Usually due to therapeutic administration:
Eg heparin or thrombin and Xa inhibitors

26
Q

What is meant by thrombosis

A 
‘Intravascular coagulation’
‘Inappropriate coagulation’
 Coagulation inside a blood vessel
‘Coagulation not preceded by bleeding’
 Thrombi may be Venous or Arterial
27
Q

What are the consequences of a thrombosis

A

Obstructed flow of blood
Artery – myocardial infarction, stroke, limb ischaemia
Vein – pain and swelling
Embolism – migration of the thrombus
Venous emboli, to lungs (pulmonary embolus)
Arterial emboli, usually from heart, may cause stroke or limb ischaemia. can lodge in peripheries- cardioembolic stroke.

28
Q

Why are the effects of pulmonary clots more dramatic

A

Lower pressure- clots have dramatic effects-

29
Q

What is thrombophilia

A

Thrombophilia is the increased risk of thrombosis; affected by multiple thromboses, young age thrombo

30
Q

Describe DVT

A

Deep vein thrombosis.
Venous return of blood is obstructed.
(painful, swollen leg)
Risk of P.E

31
Q

Describe P.E

A

Pulmonary embolism (SoB, chest pain, sudden death)

32
Q

What is the prevalence of venous thromboembolism

A

Overall 1 in 1000 - 10 000 per annum
Incidence doubles with each decade
PE is cause of 10% of hospital deaths

Estimated 25k preventable deaths per annum

33
Q

Describe venous thrombosis and age

A

Risk of P.E increases more than DVT.

34
Q

What are the consequences of thrombo-embolism

A

Death – VT mortality 5%.

  • Recurrence – 20% in first 2 years and 4% pa thereafter.
  • Thrombophlebitic Syndrome (swelling and ulcers in the leg due to damage to valves leading to stasis).
  • Pulmonary Hypertension – 4% get it at 2 years.
35
Q

What are the risk factors for thrombo-embolism

A

Genetic constitution
Effect of age and previous events, illnesses, medication
Acute stimulus

36
Q

Ultimately, describe thrombosis risk

A

multi-causal due to interacting genetic and acquired risk factors; risk increases with age, and will only get thrombus when threshold reached

37
Q

How do genetic and acquired factors cause an increased risk of thrombosis?

A

Virchow’s triad: There are three contributory factors to thrombosis:
blood dominant in venous thrombosis
vessel wall dominant in arterial thrombosis
flow complex, contributes to both
These may be inherited or acquired

38
Q

Describe the defects in the blood in thrombosis risk (hypercoagulability)

A
  • Deficiency of anticoagulant proteins.
    o E.G. Antithrombin, Protein C and S.
  • Increased Coagulant Proteins/Activity.
    o E.G. F8, F2, F5 Leiden (activated protein C resistance), Thrombocytosis (increased platelets).
39
Q

Describe FV Leiden

A

Hereditary defects in white Caucasians
Resistance to protein C
Balance tips in favour of thrombosis.

40
Q

Describe the role of endothelial injury in increased thrombosis

A

Inflammation expression: malignancy, infection, immune disorders may lead to overexpression of thrombomodulin and tissue factors

We know relatively little about the role of
the vessel wall in thrombosis.

Many proteins active in coagulation are expressed on the surface of endothelial cells eg:
Thrombomodulin
Tissue factor
Tissue factor pathway inhibitor

41
Q

Describe the role of flow in increased risk of thrombosis

A

Reduced flow increases risk of venous thrombosis- coagulation factors more likely to accumulate.

  • Increased flow may wash away coagulation factors and give less chance for a thrombus to form.
  • Caused by: surgery, fracture, long rest etc
42
Q

Describe thrombophilia

A 
Clinical:
Thrombosis at young age
‘idiopathic thrombosis’
Multiple thromboses
Thrombosis whilst anticoagulated
Laboratory
Identifiable cause of increased risk
AT deficiency, Factor V Leiden, global measures of coagulation activity.
43
Q

What are the combined risks for thrombosis

A 
Numerous conditions will alter blood coagulation, vessel wall and/or flow to precipitate thrombosis or make it more likely. Eg:
Pregnancy
Malignancy
Surgery
Inflammatory response
44
Q

Describe the lysis of clots to treat venous thrombosis

A

use of tPA (plasminogen activator) to lyse fibrin, but high risk of bleeding- ONLY USE IN SEVERE CLOTS

45
Q

Describe treatment to limit recurrence/extension/emboli

A

Increase anticoagulant activity
e.g: heparin (immediate acting, parenteral)

Lower procoagulant factors
e.g.: warfarin (oral, slow acting for long term therapy)

Inhibit procoagulant factors– direct inhibitors
Rivaroxaban (Xa), Apixaban (Xa), Dabigatran (IIa)

46
Q

What are the NICE guidelines for the prevention of VT

A

Assess individual risk and circumstantial risk
All patients admitted should have VTE risk assessment
(hospital target >90%)
Give prophylactic antithrombotic therapy
(eg heparin for in-patients)
+/ TED stockings

47
Q

Describe the importance of identifying those at risk form VTE

A

Identify while in high risk environment of hospital- before surgery
Ensure scale is not tipped too far (e.g in haemophiliacs)

48
Q

In patents with Factor V Leiden, what do they have to be

A

Heterozygous- homozygous= complete deficiency- not compatible with life.

Cardiovascular system (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions